Corp
Alkem Laboratories launches Perampil Tablets at affordable prices for epilepsy treatment
Alkem Laboratories Ltd has launched of Perampil (Perampanel) tablets 2 mg/4 mg/6 mg on June 9th 2021 to make the treatment accessible to patients and healthcare providers improving their quality of life
Representational Image/dreamstime image
New Delhi: Alkem Laboratories Ltd has launched Perampil (Perampanel) tablets 2 mg/4 mg/6 mg on June 9th 2021 to make the treatment accessible to patients and healthcare providers improving their quality of life.
Alkem has launched Perampil, at 2 mg – Rs. 49/strip of 7 tablets, 4 mg – Rs. 180/strip of 15 tablets and 6 mg – Rs300/strip of 15 tablets, to improve patient access.
The Company confirmed this product reaffirms Alkem’s commitment towards improving epilepsy care by bringing multiple treatment options of quality products to patients and health care professionals in India.
Alkem had also launched Brivasure (Brivaracetam) tablets in March 2021 for the adjunctive management of partial-onset seizure with or without secondary generalization.
The drug, Perampanel, has been approved by the Drugs Controller General of India (DCGI), as adjunctive therapy in the treatment of partial-onset
seizures in patients with epilepsy aged 4 years and older and also as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients with epilepsy aged 12 years and older.
Alkem continues to work persistently towards the production of top-quality products to improve patient access and quality of life for them.
News Must Read
- Sushil Sharma assumes additional charge of CMD, and Director (Personnel) of SJVN Limited
- Coal India Limited Board recommends final dividend, here to know
- Dr. Subhransu Sekhar Acharya assumes charge of NSIC CMD
- CIL reports mixed bag of results for Q4 of FY23-24
- NMDC's Promising Start to FY25, Targets 50 Million Tonnes
- RITES to take assessment for Vande Bharat Trains
- RBI cancels Certificate of Registration of Acemoney (India) Limited due to irregular lending practices
- Coal India Production rises by 7 percent in April
- WAPCOS became second Indian PSU in ADB Consulting
- Power Grid appoints Satyaprakash Dash as CS and Compliance Officer